›› 2018, Vol. 36 ›› Issue (11): 880-.doi: 10.3969/j.issn.1000-3606.2018.11.019

Previous Articles     Next Articles

Features and clinical significance of IKZF1 aberrations in childhood B-cell acute lymphoblastic leukemia

Reviewer: BI Junqin1,  Reviser: BAO Liming1,2   

  1. 1.Center for Clinical Molecular Medicine,Ministry of Education Key Laboratory of Child Development Disorders, Chongqing Key Laboratory of Pediatrics, Children’ Hospital of Chongqing Medical University, Chongqing 400014, China; 2.Department of Pathology and Laboratory Medicine and Geisel School of Medicine at Dartmouth College, New Hampshire 03756, USA
  • Received:2018-11-15 Online:2018-11-15 Published:2018-11-15

Abstract:  IKAROS family zinc finger 1 (IKZF1) gene encoding a zinc finger transcription factor IKAROS plays an important role in the regulation of B lymphoid cell differentiation and proliferation. IKZF1 is a clinical tumor suppressive factor. Deletion of IKZF1 results in either haploinsufficiency or dominating negative for IKAROS that contributes to the development of B-cell acute lymphoblastic leukemia (B-ALL), associated with an poor prognosis. Study of IKZF1 may lead to identifying new risk stratification molecular indicator for B-ALL for a better guidance to individualized therapy.